These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 33685566

  • 1. Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis.
    Zhou J, Chen S, Song Z.
    Allergy Asthma Proc; 2021 Mar 01; 42(2):e47-e54. PubMed ID: 33685566
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, Bieber T, Thomas WR, Valenta R, Zuberbier T, Sager A, Novak N.
    Clin Exp Allergy; 2007 Sep 01; 37(9):1277-85. PubMed ID: 17845407
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
    Huang HH, Xu C, Liu L, Chai RN.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun 06; 56(6):774-783. PubMed ID: 35785859
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aqueous intradermal low-dose house dust mite immunotherapy in tropical settings: a valid cost-effective approach for developing nations?
    Rondon C, Sánchez-Borges M, Cupello ER, Fabiano F, Capriles-Hulett A.
    Allergol Immunopathol (Madr); 2021 Jun 06; 49(2):31-39. PubMed ID: 33641291
    [Abstract] [Full Text] [Related]

  • 7. A large scale multicentre randomized, placebo-controlled subcutaneous house dust mite allergen immunotherapy (HDM SCIT) in allergic rhinitis: MITAR Study.
    Suratannon N, Limsuwan T, Tantilipikorn P, Chatchatee P, Saengapaswiriya A, Boonpiyathad T, Thongngarm T, Roongpuvapaht B, Chantaphakul H, Kulalert P, Thanaviratananich S, Sangsupawanich P, Fooanant S, Manuyakorn W, Chusakul S, Piboonpochanun O, Apornpong T, Wongpiyabovorn J, Ruxrungtham K, MITAR Study Group.
    Asian Pac J Allergy Immunol; 2024 Sep 06; 42(3):233-245. PubMed ID: 39417769
    [Abstract] [Full Text] [Related]

  • 8. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
    Kwon YS, Oh SH, Wu WH, Bae BG, Lee HJ, Lee MG, Lee KH.
    Exp Dermatol; 2010 Mar 06; 19(3):246-51. PubMed ID: 19758316
    [Abstract] [Full Text] [Related]

  • 9. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
    Yepes-Nuñez JJ, Guyatt GH, Gómez-Escobar LG, Pérez-Herrera LC, Chu AWL, Ceccaci R, Acosta-Madiedo AS, Wen A, Moreno-López S, MacDonald M, Barrios M, Chu X, Islam N, Gao Y, Wong MM, Couban R, Garcia E, Chapman E, Oykhman P, Chen L, Winders T, Asiniwasis RN, Boguniewicz M, De Benedetto A, Ellison K, Frazier WT, Greenhawt M, Huynh J, Kim E, LeBovidge J, Lind ML, Lio P, Martin SA, O'Brien M, Ong PY, Silverberg JI, Spergel J, Wang J, Wheeler KE, Schneider L, Chu DK.
    J Allergy Clin Immunol; 2023 Jan 06; 151(1):147-158. PubMed ID: 36191689
    [Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of two commercial house dust mite extracts for allergic rhinitis: a head-to-head study.
    Li J, Wu Y, Yang Y, Huang N, Li W, Zhang S, Jiang Q, Yang L, Zhu R.
    Int Forum Allergy Rhinol; 2019 Aug 06; 9(8):876-882. PubMed ID: 31322838
    [Abstract] [Full Text] [Related]

  • 11. Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products.
    Park KH, Lee SC, Son YW, Jeong KY, Shin YS, Shin JU, Sim da W, Park HJ, Lee JH, Lee KH, Park JW.
    Yonsei Med J; 2016 Nov 06; 57(6):1427-34. PubMed ID: 27593871
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens.
    Chen S, Zheng Y, Chen B, Zhong H, Liao F, Wang L, Hui SF, Lai X.
    Int Arch Allergy Immunol; 2019 Nov 06; 178(2):201-210. PubMed ID: 30544116
    [Abstract] [Full Text] [Related]

  • 15. Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model.
    Hesse L, van Ieperen N, Habraken C, Petersen AH, Korn S, Smilda T, Goedewaagen B, Ruiters MH, van der Graaf AC, Nawijn MC.
    Allergy; 2018 Apr 06; 73(4):862-874. PubMed ID: 29318623
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Langer SS, Cardili RN, Melo JML, Ferriani MPL, Moreno AS, Dias MM, Bueno-Filho R, Pocente RHC, Roxo-Junior P, Silva J, Valera FCP, Coelho EB, Galvão CES, Carmona F, Aragon DC, Arruda LK.
    J Allergy Clin Immunol Pract; 2022 Feb 06; 10(2):539-549.e7. PubMed ID: 34767999
    [Abstract] [Full Text] [Related]

  • 17. Immunoglobulin G1 subclass responses can be used to detect specific allergy to the house dust mites Dermatophagoides farinae and Dermatophagoides pteronyssinus in atopic dogs.
    Khantavee N, Chanthick C, Tungtrongchitr A, Techakriengkrai N, Suradhat S, Sookrung N, Roytrakul S, Prapasarakul N.
    BMC Vet Res; 2021 Feb 05; 17(1):71. PubMed ID: 33546688
    [Abstract] [Full Text] [Related]

  • 18. The IgE Blocking Activity Induced by Dermatophagoides pteronyssinus Subcutaneous Immunotherapy Does Not Correlate with Specific IgA but with IgG4 in both Serum and Saliva.
    He Y, Liu J, Zhao D, Zhang S, Hao G, Sun Y, Zhong H, Chen H, Würtzen PA, Larsen JN, Lai X.
    Int Arch Allergy Immunol; 2021 Feb 05; 182(12):1231-1244. PubMed ID: 34280916
    [Abstract] [Full Text] [Related]

  • 19. The indoor level of house dust mite allergen is associated with severity of atopic dermatitis in children.
    Kim J, Lee S, Woo SY, Han Y, Lee JH, Lee IY, Lim IS, Choi ES, Choi BW, Cheong HK, Lee SI, Ahn K.
    J Korean Med Sci; 2013 Jan 05; 28(1):74-9. PubMed ID: 23341715
    [Abstract] [Full Text] [Related]

  • 20. [Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with allergic disease].
    Molina-Sáenz MM, Villa-Arango AM, Cardona-Villa R.
    Rev Alerg Mex; 2017 Jan 05; 64(1):52-65. PubMed ID: 28188713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.